Bzl-L-Pro-OH

Bzl-L-Pro-OH is an L-proline derivative bearing a benzyl (Bzl) protecting group on the ring nitrogen, with a free carboxylic acid at the α-position. The molecule combines a rigid, stereodefined cyclic amino acid framework with a chiral center that controls peptide coupling stereochemistry and downstream conformational behavior. The N-benzyl protection suppresses undesired N-acylation or side reactions during peptide assembly, while the carboxylic acid remains available for activation to form amide bonds. The resulting reactivity profile makes Bzl-L-Pro-OH a practical chiral amino acid intermediate for protected amino acid synthesis and for constructing proline-containing peptide segments with controlled N-protection strategies.

1. Protected Amino Acid Synthesis

Bzl-L-Pro-OH is applied in protected amino acid synthesis and chiral intermediate preparation for peptide building block workflows. The N-benzyl (Bzl) group protects the proline nitrogen during carboxyl activation, while the free α-carboxylic acid supports conversion to activated esters or coupling-ready derivatives. The L stereochemistry and proline ring rigidity help maintain stereochemical integrity through peptide coupling steps and subsequent transformations. The benzyl-protected nitrogen can be removed under hydrogenolysis-compatible conditions to regenerate the free proline amine for further derivatization, enabling controlled N-deprotection sequences in synthetic campaigns. Bzl-L-Pro-OH thus functions as a structured intermediate for N-protected proline incorporation and downstream peptide assembly chemistry.

2. Peptide Synthesis Compatibility

Bzl-L-Pro-OH is suitable for peptide synthesis where proline residues require orthogonal N-protection relative to other side-chain protecting groups. The protected ring nitrogen reduces competing reactions during amide bond formation, and the free carboxylic acid enables peptide coupling chemistry to install the proline residue at either the C-terminal position (after activation) or as a protected amino acid component in stepwise synthesis. The cyclic proline scaffold influences backbone conformation and can be leveraged to construct peptides with defined turns, bends, or constrained secondary structure motifs. The N-benzyl protection strategy can be integrated with common protecting-group schemes, allowing selective deprotection to reveal the proline amine when needed for chain extension or cyclization. Bzl-L-Pro-OH therefore supports realistic peptide construction and protected amino acid coupling routes used in research-grade and manufacturing-relevant peptide intermediate supply chains.

3. Chiral Building Block Development

Bzl-L-Pro-OH is used as a chiral amino acid intermediate for stereoselective synthesis of proline-containing fragments and peptidomimetic scaffolds. The L-configuration at the α-carbon provides a defined stereochemical handle for building chiral amide linkages, while the N-benzyl group stabilizes the nitrogen functionality against premature derivatization. The rigid proline ring can be carried through to downstream transformations that generate constrained analogs, including N-functionalized derivatives after deprotection. The free carboxylic acid supports conversion into coupling partners for fragment assembly, enabling modular synthesis of chiral libraries and structure-defined intermediates. Bzl-L-Pro-OH thereby serves as a stereochemically controlled platform for chiral synthesis programs that rely on protected amino acid chemistry.

4. Side-Chain Functionalization

Bzl-L-Pro-OH is applied in side-chain functionalization and derivatization strategies that begin from a protected proline framework. The benzyl-protected nitrogen can be maintained during carboxyl-based activation and coupling, then selectively transformed after N-deprotection to introduce alternative N-substituents such as alkyl, acyl, or linker-bearing groups for conjugation or scaffold tuning. The presence of a carboxylic acid enables formation of amides, esters, or activated intermediates that can be further elaborated into functional groups relevant to biochemical probes or material-bound motifs. The conformational constraints of the proline ring can translate into predictable spatial orientation of the resulting functional groups, supporting rational design of amino acid derivatives for downstream molecular recognition studies. Bzl-L-Pro-OH thus supports functionalized amino acid analog preparation where controlled N-protection and carboxyl reactivity are central to the synthetic sequence.

5. Pharmaceutical Intermediate Preparation

Bzl-L-Pro-OH is relevant to pharmaceutical intermediate preparation and process chemistry as a protected proline derivative that fits into controlled N-protection and deprotection logic. The N-benzyl group provides a stable nitrogen protection mode during activation of the carboxylic acid and formation of amide-linked intermediates used in medicinal chemistry synthesis. The free α-carboxylic acid enables scalable conversion to coupling-ready forms that can be incorporated into larger synthetic sequences, including proline-containing fragments for peptidomimetics and constrained backbone analogs. The stereodefined L configuration supports consistent stereochemical outcomes in downstream coupling and late-stage assembly steps. Bzl-L-Pro-OH therefore serves as a practical chiral amino acid intermediate for industrial fine chemical synthesis programs requiring reproducible protected amino acid handling and controlled nitrogen deprotection.

1. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

2. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

3. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

4. Implications of ligand-receptor binding kinetics on GLP-1R signalling

5. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries